Celso E Gomez-Sanchez Selected Research

metomidate

1/2022	11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial.
1/2021	Response to Letter on use of functional imaging by 11C-metomidate PET for primary aldosteronism subtyping.
12/2020	Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Celso E Gomez-Sanchez Research Topics

Disease

60	Adenoma (Adenomas) 01/2022 - 03/2004
45	Hyperaldosteronism (Conn Syndrome) 01/2022 - 01/2002
25	Hypertension (High Blood Pressure) 12/2020 - 01/2002
14	Hyperplasia 12/2021 - 09/2008
13	Neoplasms (Cancer) 12/2021 - 06/2008
7	Adrenocortical Adenoma (Disease, Conn's) 01/2022 - 10/2016
6	Muscular Dystrophies (Muscular Dystrophy) 01/2022 - 01/2016
6	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022 - 11/2015
6	Obesity 01/2021 - 03/2012
5	Familial Hyperaldosteronism 12/2021 - 04/2012
4	Carcinogenesis 10/2021 - 01/2016
4	Inflammation (Inflammations) 01/2021 - 07/2014
4	Adrenocortical Carcinoma 07/2020 - 04/2012
4	Heart Failure 12/2016 - 03/2004
3	Cushing Syndrome 12/2021 - 12/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 03/2012
3	Glucocorticoid-Remediable Aldosteronism 01/2018 - 01/2002
3	Essential Hypertension 01/2017 - 03/2012
3	Hypokalemia 09/2008 - 06/2003
2	3 Autosomal Dominant Hypercholesterolemia 12/2021 - 01/2017
2	Wounds and Injuries (Trauma) 01/2019 - 12/2016
2	Fibrosis (Cirrhosis) 01/2019 - 12/2015
2	Channelopathies 12/2018 - 01/2014
2	Infections 08/2007 - 08/2006
1	Pituitary ACTH Hypersecretion 03/2021
1	Pituitary Neoplasms (Pituitary Adenoma) 03/2021
1	Heart Diseases (Heart Disease) 01/2019
1	Endocrine System Diseases (Endocrine Diseases) 01/2018
1	Chronic Disease (Chronic Diseases) 12/2016

Drug/Important Bio-Agent (IBA)

77	AldosteroneIBA 01/2022 - 03/2004
27	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2022 - 07/2002
15	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 06/2003
13	ReninIBA 01/2020 - 01/2002
11	EnzymesIBA 01/2022 - 06/2003
11	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 07/2020 - 07/2002
10	SteroidsIBA 07/2020 - 01/2002
8	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 06/2003
8	GlucocorticoidsIBA 01/2021 - 07/2002
7	18-oxocortisolIBA 01/2019 - 09/2002
6	Angiotensin IIIBA 06/2020 - 02/2011
6	Hormones (Hormone)IBA 12/2017 - 01/2002
6	Potassium Channels (Potassium Channel)IBA 01/2017 - 02/2012
5	MineralocorticoidsIBA 01/2018 - 01/2002
5	SodiumIBA 01/2014 - 01/2002
4	Ion Channels (Ion Channel)IBA 06/2020 - 06/2015
4	18-hydroxycortisolIBA 01/2018 - 09/2002
4	Mineralocorticoid Receptor AntagonistsIBA 01/2018 - 09/2008
4	SaltsIBA 11/2017 - 01/2008
4	Spironolactone (Aldactone)FDA LinkGeneric 06/2017 - 02/2011
3	metomidateIBA 01/2022 - 12/2020
3	CateninsIBA 12/2021 - 01/2016
3	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 06/2015
3	GTP-Binding Proteins (G-Protein)IBA 12/2020 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 07/2020 - 07/2014
3	Monoclonal AntibodiesIBA 10/2019 - 07/2014
3	Type 1 Angiotensin ReceptorIBA 12/2018 - 02/2011
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 01/2016
3	PotassiumIBA 12/2015 - 12/2013
3	CalciumIBA 08/2015 - 04/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2017
2	CytokinesIBA 01/2022 - 01/2021
2	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 12/2020 - 10/2019
2	LigandsIBA 01/2019 - 08/2015
2	AutoantibodiesIBA 12/2018 - 05/2014
2	AntibodiesIBA 12/2017 - 11/2017
2	3 beta-hydroxysteroid dehydrogenase type IIIBA 11/2017 - 06/2015
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2017 - 04/2014
2	Lisinopril (Prinivil)FDA LinkGeneric 06/2017 - 11/2015
2	Biomarkers (Surrogate Marker)IBA 06/2017 - 08/2011
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 03/2017 - 02/2016
2	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 08/2014
2	CorticosteroneIBA 12/2015 - 02/2005
2	Calcium Channels (Calcium Channel)IBA 06/2015 - 01/2014
2	11-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)IBA 06/2008 - 06/2003
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 10/2021
1	Cytidine Triphosphate (CTP)IBA 03/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	steroidogenic acute regulatory proteinIBA 07/2020
1	calmeginIBA 01/2020
1	barium chloride (barium dichloride)IBA 01/2019
1	Capsules (Microcapsules)IBA 01/2019
1	Chemokine ReceptorsIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	AngiotensinsIBA 01/2018
1	CXCR ReceptorsIBA 01/2018
1	UtrophinIBA 01/2018
1	DystrophinIBA 01/2018
1	ParaffinIBA 12/2017
1	Ion Pumps (Ion Pump)IBA 12/2017
1	CryptochromesIBA 11/2017
1	Prednisolone (Predate)FDA LinkGeneric 06/2017
1	Mixed Function Oxygenases (Monooxygenases)IBA 03/2017
1	LyasesIBA 03/2017
1	Fluconazole (Zonal)FDA LinkGeneric 01/2017

Therapy/Procedure

8	Adrenalectomy 12/2021 - 09/2008
4	Therapeutics 01/2020 - 03/2012
2	Injections 01/2019 - 02/2011
1	Radiotherapy 03/2021